Actively Recruiting
Cell-Free DNA Chromatin Immunoprecipitation (ChIP) for Diagnosing Cancer
Led by University of Central Florida · Updated on 2024-12-06
24
Participants Needed
1
Research Sites
101 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this research is to use chromatin immunoprecipitation, a method used to study protein-DNA interaction, as a tool to diagnose and prognose pancreatic ductal adenocarcinoma in human samples. This is a Non-Human Subject Research study. All participants are de-identified.
CONDITIONS
Official Title
Cell-Free DNA Chromatin Immunoprecipitation (ChIP) for Diagnosing Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years old or older
- Diagnosed with pancreatic cancer
You will not qualify if you...
- Children under 18 years may not register
- Persons unable to provide informed consent may not register
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Central Florida
Orlando, Florida, United States, 32816
Actively Recruiting
Research Team
A
Amoy Fraser, PhD, CCRP, PMP
CONTACT
E
Erica Martin, B.S.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here